Cochlear (CHEOY) Short Interest Ratio & Short Volume → Biden to Drop BOMBSHELL June 13th? (From Paradigm Press) (Ad) Free CHEOY Stock Alerts $112.86 +0.10 (+0.09%) (As of 04:16 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartDividendFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisAnalyst ForecastsChartDividendFinancialsHeadlinesSEC FilingsShort Interest Cochlear Short Interest DataCurrent Short Volume2,100 sharesPrevious Short Volume1,200 sharesChange Vs. Previous Month+75.00%Dollar Volume Sold Short$222,957.00Short Interest Ratio / Days to Cover0.2Last Record DateApril 30, 2024Outstanding Shares130,990,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume5,450 sharesAverage Trading Volume3,396 sharesToday's Volume Vs. Average160% Short Selling Cochlear ? Sign up to receive the latest short interest report for Cochlear and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCHEOY Short Interest Over TimeCHEOY Days to Cover Over TimeCHEOY Percentage of Float Shorted Over Time Ad Weiss RatingsThis is the best new way to score with AIIf you thought that you missed your chance to score big on AI, I have great news. A rare second profit window is starting to open.Click now for the best way into the newest AI projects Cochlear Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20242,100 shares $222,957.00 +75.0%N/A0.2 $106.17 4/15/20241,200 shares $124,584.00 -42.9%N/A0.2 $103.82 3/31/20242,100 shares $231,329.28 +200.0%N/A0.3 $110.16 3/15/2024700 shares $76,335.00 -80.0%N/A0.1 $109.05 2/29/20243,500 shares $396,410.00 -31.4%N/A0.7 $113.26 2/15/20245,100 shares $554,859.60 +466.7%N/A0.7 $108.80 Get the Latest News and Ratings for CHEOY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cochlear and its competitors with MarketBeat's FREE daily newsletter. 1/15/20241,300 shares $128,570.00 -38.1%N/A0.4 $98.90 12/31/20232,100 shares $212,919.00 -16.0%N/A0.5 $101.39 12/15/20232,500 shares $250,162.50 +150.0%N/A0.3 $100.07 11/30/20231,000 shares $89,906.00 -88.1%N/A0.2 $89.91 11/15/20238,400 shares $703,752.00 No ChangeN/A0.7 $83.78 10/15/2023600 shares $48,438.00 -83.8%N/A0.1 $80.73 9/30/20233,700 shares $303,289.00 -79.3%N/A0.2 $81.97 9/15/202317,900 shares $1.51 million -35.4%N/A1.4 $84.50 8/31/202327,700 shares $2.43 million +403.6%N/A1.4 $87.90 8/15/20235,500 shares $434,500.00 +103.7%N/A0.3 $79.00 7/31/20232,700 shares $217,539.00 -15.6%N/A0.3 $80.57 7/15/20233,200 shares $252,672.00 -65.2%N/A0.2 $78.96 6/30/20239,200 shares $703,708.00 +39.4%N/A0.6 $76.49 6/15/20236,600 shares $542,044.80 +2,100.0%N/A0.7 $82.13 5/31/2023300 shares $23,748.00 -76.9%N/A0 $79.16 5/15/20231,300 shares $108,527.90 -48.0%N/A0.4 $83.48 4/30/20232,500 shares $203,900.00 +4.2%N/A0.6 $81.56 4/15/20232,400 shares $199,104.00 +4.4%N/A0.5 $82.96 3/31/20232,300 shares $182,137.00 -82.2%N/A0.2 $79.19 3/15/202312,900 shares $957,696.00 +200.0%N/A0.9 $74.24 2/28/20234,300 shares $323,059.00 +65.4%N/A0.8 $75.13 2/15/20232,600 shares $202,904.00 -77.6%N/A0.5 $78.04 1/31/202311,600 shares $871,972.00 +84.1%N/A2.2 $75.17 1/15/20236,300 shares $459,396.00 +1.6%N/A0.6 $72.92 12/30/20226,200 shares $427,676.00 +1.6%N/A0.3 $68.98 12/15/20226,100 shares $424,072.00 +125.9%N/A0.5 $69.52 11/30/20222,700 shares $196,749.00 -10.0%N/A0.2 $72.87 11/15/20223,000 shares $207,390.00 +400.0%N/A0.1 $69.13 10/31/2022600 shares $38,052.00 -60.0%N/A0 $63.42 10/15/20221,500 shares $88,980.00 -71.7%N/A0 $59.32 9/30/20225,300 shares $331,621.00 -7.0%N/A0.1 $62.57 9/15/20225,700 shares $404,073.00 +67.7%N/A0.3 $70.89 8/31/20223,400 shares $248,577.40 +142.9%N/A0.6 $73.11 8/15/20221,400 shares $108,724.00 -65.9%N/A0.1 $77.66Charles Payne Demystifies Options (Ad)When it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. Click here to register for free. CHEOY Short Interest - Frequently Asked Questions What is Cochlear's current short interest? Short interest is the volume of Cochlear shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 2,100 shares of CHEOY short. Learn More on Cochlear's current short interest. Is Cochlear's short interest increasing or decreasing? Cochlear saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 2,100 shares, an increase of 75.0% from the previous total of 1,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Cochlear's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Cochlear: Ambu A/S (0.00%), Neurocrine Biosciences, Inc. (1.82%), Shionogi & Co., Ltd. (0.00%), Viatris Inc. (3.84%), Revvity, Inc. (2.09%), Incyte Co. (4.29%), Bio-Techne Co. (3.76%), Fresenius Medical Care AG (0.24%), Sandoz Group AG (0.29%), BioMarin Pharmaceutical Inc. (2.06%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Cochlear stock? Short selling CHEOY is an investing strategy that aims to generate trading profit from Cochlear as its price is falling. CHEOY shares are trading up $4.42 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cochlear? A short squeeze for Cochlear occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CHEOY, which in turn drives the price of the stock up even further. How often is Cochlear's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CHEOY, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: AMBBY Short Interest Data NBIX Short Interest Data SGIOY Short Interest Data VTRS Short Interest Data RVTY Short Interest Data INCY Short Interest Data TECH Short Interest Data FMS Short Interest Data SDZNY Short Interest Data BMRN Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:CHEOY) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBiden to Drop BOMBSHELL June 13th?Paradigm PressElon to Transform U.S. Economy? Porter & CompanyCharles Payne Demystifies OptionsUnstoppable ProsperityThe most important AI company you've never heard ofManward PressThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyElon’s New Device is About to Shock the WorldInvestorPlaceGold ManiaStansberry Research